DIR Fee Controversy Shaping the Future of Pharmacy

coapharm2017-12-28T17:00:19+00:00December 28, 2017|

Renacci leads bipartisan battle to stay Medicare reimbursement rate for safety-net hospitals

coapharm2017-12-28T16:55:40+00:00December 28, 2017|

Anthem Signals Intent To Compete With Optum In Buying Providers

coapharm2017-12-27T17:09:50+00:00December 27, 2017|

What We Mean When We Say Evidence-Based Medicine

coapharm2017-12-27T17:08:58+00:00December 27, 2017|

The uninsured are overusing emergency rooms — and other health-care myths

coapharm2017-12-27T17:07:49+00:00December 27, 2017|

Cancer Drug Price Rises 1,400% With No Generic to Challenge It

coapharm2017-12-26T16:00:17+00:00December 26, 2017|

Lawmakers introduce 340B legislation to step up program oversight

coapharm2017-12-22T14:18:09+00:00December 22, 2017|

Judge to decide 340B cuts’ fate soon

coapharm2017-12-22T14:17:02+00:00December 22, 2017|

Report: 340B Drug Program Rife with Abuse, Profiteering

coapharm2017-12-21T14:26:23+00:00December 21, 2017|

Did Your Prescription Drug Change? This May Be Why

coapharm2017-12-21T14:22:31+00:00December 21, 2017|